Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
Objectives: To evaluate the efficacy and safety of Serenoa repens + selenium and lycopene (Profluss®) versus S. repens alone for the treatment of category IIIa chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Patients and Methods: 102 patients with IIIa CP/CPPS were enrolled and randomized into two groups each to receive Profluss or S. repens alone for 8 weeks. Evaluation was based on results of the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), IPSS, maximum peak flow rate (MPFR), and PSA measurements at baseline and at weeks 4, 8 and 8 after the end of treatment. The primary endpoint was a >50% reduction in NIH-CPSI score. Secondary endpoints evaluated were MPFR, IPSS, PSA and white blood cell count. Results: No patients withdrew from the study. The mean NIH-CPSI score decreased significantly (p < 0.001) in both groups; we observed a decrease in the total score from 27.45 to 13.27 in group 1 (–51.64%) and from 27.76 to 20.62 in group 2 (–26.06%). IPSS improved significantly (p < 0.001) in both arms, but more in group 1. PSA and white blood cell count decreased significantly (p < 0.007) only in group 1. The MPFR improved more in group 1 (p < 0.005). Conclusion: Profluss is a triple therapy that is safe and well tolerated. It ameliorates symptoms associated with IIIa CP/CPPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prospective, comparative trial provides additional evidence that phytotherapy offers symptom improvement in inflammatory CP/CPPS, with significant changes in symptoms from baseline observed for Profluss® (Serenoa repens, selenium, and lycopene) 102.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- 10.1111%2Fj.1464-410X.2005.05341.x · DOI
- 10.1016%2FS0090-4295%2898%2900034-X · DOI · Paper page
- 10.1046%2Fj.1464-410X.2000.00836.x · DOI · Paper page
- 10.1016%2FS0022-5347%2805%2965301-3 · DOI · Paper page
- 10.1001%2Fjama.282.3.236 · DOI · Paper page
- 10.1146%2Fannurev.med.57.011205.135654 · doi:10.1146/annurev.med.57.011205.135654
- 10.1016%2FS0022-5347%2801%2966359-6 · DOI · Paper page
- 10.1111%2Fj.1525-1497.2001.01223.x · DOI · Paper page
- 10.1001%2Farchinte.164.11.1231 · DOI
- 10.1016%2FS0022-5347%2805%2968562-X · DOI · Paper page
- 10.1016%2FS0094-0143%2805%2970215-9 · doi:10.1016/s0094-0143(05)70215-9
- 10.1016%2Fj.urology.2003.11.002 · DOI
- 10.1016%2Fj.mehy.2004.11.039 · doi:10.1016/j.mehy.2004.11.039
- 10.1517%2F14796694.1.3.425 · DOI
- 10.1188%2F06.ONF.127-137 · DOI
- 10.1016%2Fj.abb.2004.04.023 · DOI · Paper page
- 10.1016%2Fj.ejpain.2007.10.008 · DOI
- 10.1016%2Fj.gassur.2005.08.035 · DOI
- 10.1016%2Fj.pbb.2006.02.002 · doi:10.1016/j.pbb.2006.02.002
- 10.1111%2Fj.1464-410X.2003.04735.x · doi:10.1111/j.1464-410x.2003.04735.x
- 10.1016%2F0960-0760%2895%2900134-L · DOI
- 10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C232%3A%3AAID-PROS4%3E3.0.CO%3B2-0 · doi:10.1002/(sici)1097-0045(19990901)40:4<232::aid-pros4>3.0.co;2-0
- 10.1002%2F%28SICI%291097-0045%2819981001%2937%3A2%3C77%3A%3AAID-PROS3%3E3.0.CO%3B2-I · DOI
- 10.1159%2F000019570 · DOI
- 10.1016%2FS0952-3278%2897%2990548-2 · DOI
- 10.1097%2F01.ju.0000101487.83730.80 · DOI · Paper page
- 10.1093%2Fecam%2Fneh128 · doi:10.1093/ecam/neh128
- 10.1016%2Fj.ijantimicag.2007.07.016 · doi:10.1016/j.ijantimicag.2007.07.016
- 10.1002%2Fmnfr.200700346 · DOI · Paper page
- 10.1097%2F00001648-200007000-00007 · DOI
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191
Metadata
- Authors
- Morgia, G., Mucciardi, G., Galì, A., Madonia, M., Marchese, F., Di Benedetto, A., Romano, G., Bonvissuto, G., Castelli, T., Macchione, L., & Magno, C.
- Venue
- Urologia Internationalis
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 84
- Issue
- 4
- Pages
- 400-406
- ISSN
- 0042-1138
- 1423-0399
- Cited by
- 49
- References
- 0
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study. https://app.cochat.ai/papers/10.1159/000302716
- The paper
- Morgia, G., Mucciardi, G., Galì, A., Madonia, M., Marchese, F., Di Benedetto, A., Romano, G., Bonvissuto, G., Castelli, T., Macchione, L., & Magno, C. (2010). Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study. Urologia Internationalis. https://doi.org/10.1159/000302716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.